Comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics".
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34851692.
- Also identified by DOI 10.1126/scitranslmed.abe8497.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genetic data do not provide evidence for SOST inhibition causing cardiovascular disease.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Cardiovascular Diseases